REMNANT CHOLESTEROL REDUCTION BY EZETIMIBE AND SIMVASTATIN DOES NOT AFFECT BILIARY LIPID CONCENTRATION IN GALLSTONE PATIENTS

被引：0
|
作者：
Eriksson, M. [1 ]
Ahmed, O. [2 ]
Gustafsson, U. [3 ]
Littman, K. [2 ]
Sahlin, S. [3 ]
Pramfalk, C. [2 ]
Parini, P. [2 ]
机构：
[1] Karolinska Inst, Dept Med, Karolinska Huddinge, Stockholm, Sweden
[2] Karolinska Inst, Dept Lab Med, Karolinska Huddinge, Stockholm, Sweden
[3] Karolinska Inst, Dept Surg, Danderyd Hosp, Stockholm, Sweden
来源：
ATHEROSCLEROSIS | 2016年 / 252卷
关键词：
D O I：
10.1016/j.atherosclerosis.2016.07.435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS16-0799
引用
收藏
页码：E62 / E62
页数：1
相关论文
共 50 条
  • [21] Ezetimibe/simvastatintherapy is more effective than simvastatin alone at reducing remnant-like particle cholesterol
    Bays, HE
    Ose, L
    Fraser, N
    Quinto, KL
    Reyes, R
    Sapre, A
    Tribble, D
    Donahue, SR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 481A - 481A
  • [22] Ezetimibe/simvastatintherapy is more effective than simvastatin alone at reducing remnant-like particle cholesterol
    Ose, L
    Bays, H
    Fraser, N
    Quinto, K
    Reyes, R
    Sapre, A
    Tribble, D
    Donahue, S
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 140 - 140
  • [23] LONG-TERM TREATMENT WITH SIMVASTATIN DOES NOT LEAD TO GALLSTONE DISSOLUTION IN PATIENTS WITH SMALL CHOLESTEROL GALLSTONES
    VANERPECUM, KJ
    SMIT, JWA
    VANBERGEHENEGOUWEN, GP
    GASTROENTEROLOGY, 1995, 108 (04) : A440 - A440
  • [24] BILIARY LIPID SECRETION IN CHOLESTEROL GALLSTONE DISEASE - EFFECT OF CHOLECYSTECTOMY AND OBESITY
    SHAFFER, EA
    SMALL, DM
    JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (05): : 828 - 840
  • [25] INFLUENCE OF CHOLECYSTECTOMY AND OBESITY ON BILIARY LIPID SECRETION IN CHOLESTEROL GALLSTONE DISEASE
    SHAFFER, EA
    SMALL, DM
    GASTROENTEROLOGY, 1976, 70 (05) : 936 - 936
  • [26] BILIARY LIPID SECRETION IN CHOLESTEROL GALLSTONE DISEASE - EFFECT OF CHOLECYSTECTOMY AND OBESITY
    SHAFFER, EA
    SMALL, DM
    CLINICAL RESEARCH, 1975, 23 (05): : A622 - A622
  • [27] EFFECTS OF PHENOBARBITAL ON BILIARY LIPID-METABOLISM IN CHOLESTEROL GALLSTONE SUBJECTS
    REDINGER, RN
    LIPIDS, 1979, 14 (03) : 277 - 284
  • [28] Cholesterol-gallstone formation: More than a biliary lipid defect?
    Van Erpecum, KJ
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2004, 144 (03): : 121 - 123
  • [29] Effect of ezetimibe/simvastatin versus simvastatin monotherapy on the lipid profile of hypercholesterolemic patients with metabolic syndrome
    Ose, L
    Feldman, T
    Zakson-Aiken, M
    Shah, A
    Maccubbin, D
    Tribble, D
    Veltri, E
    Mitchel, Y
    DIABETOLOGIA, 2005, 48 : A393 - A393
  • [30] BILIARY LIPID MASS WITHIN THE GALLBLADDER (GB) IN CHOLESTEROL GALLSTONE PATIENTS, AND THE EFFECT OF URSODEOXYCHOLIC ACID (UDCA)
    JAZRAWI, R
    GALATOLA, G
    NORTHFIELD, TC
    GASTROENTEROLOGY, 1987, 92 (05) : 1741 - 1741
12345